Infectious Diseases Search
Infectious Diseases Infectious Diseases
molluscum%20contagiosum
MOLLUSCUM CONTAGIOSUM
Molluscum contagiosum is an infection due to poxvirus that results into discrete skin lesions with central umbilication.
Spread is by skin-to-skin contact, fomites spread and autoinoculation.
Patients with atopic dermatitis, HIV or immunodeficiency are particularly susceptible.
Incubation period may be from 2-7 weeks.
In children, it usually presents with lesions on the face, scalp, ears, trunk and extremities and crural folds while in adults, it is typically sexually transmitted and affects the groin, genital area, thighs and lower abdomen.

Molluscum Contagiosum Drug Information

Drug Information

Indication: External genital & perianal warts. Actinic keratoses. Superficial basal cell carcinoma.

Indication: Active duodenal, benign gastric, stomal & recurrent ulceration, persistent dyspeptic symptoms w/ or w/o ul...

Duofilm
lactic acid + salicylic acid

Indication: Warts, corns & calluses.

Indication: Corns, warts & calluses.

Indication: Acne vulgaris.

Indication: Duodenal & gastric ulcer, GERD (including heartburn & peptic oesophagitis), persistent dyspepsia &...

T3 Acne Body Spray
allantoin + salicylic acid + triclosan

Indication: Reduces acne & pimple spots on back, chest, neck & arms.

Indication: Acne vulgaris.

Verrumal
dimethylsulfoxide + fluorouracil + salicylic acid

Indication: Common, flat juvenile & plantar warts.

1  /  3
1  /  3
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
COVID-19 pandemic causes drop in cardiovascular diagnostic testing
3 days ago
Diagnosis of heart diseases has abruptly and significantly decreased across the globe due to the coronavirus disease 2019 (COVID-19) pandemic, especially affecting poorer countries, reveals a study.
Pfizer and BioNTech are testing 4 novel vaccines in Europe and US.
Pank Jit Sin, 13 May 2020
A trial vaccine for the prevention of COVID-19 is underway with the first US participants being dosed in the Phase 1/2 clinical trial. Known as the BNT162 vaccine programme, the trials are a collaboration between Pfizer Inc. and BioNTech SE, and is part of a global development programme with Germany and the US taking the lead in having the first cohorts to be vaccinated. Germany started the study 1 week earlier.